Journal of ISSN: 2373-6437JACCOA

Anesthesia & Critical Care: Open Access
Case Report
Volume 5 Issue 6 - 2016
Epidural Anaesthesia a Safe Option for Caesarean Section in Parturient with Severe Pulmonary Hypertension - A Case Report
Sreyashi Sen*
Medical college Kolkata, India
Received: September 04, 2015 | Published: October 04, 2016
*Corresponding author: Sreyashi Sen, Medical college Kolkata, 88 College Street, Kolkata, 700073, India, Tel: 9433652367; Email:
Citation: Sen S (2016) Epidural Anaesthesia a Safe Option for Caesarean Section in Parturient with Severe Pulmonary Hypertension - A Case Report. J Anesth Crit Care Open Access 5(6): 00207. DOI: 10.15406/jaccoa.2016.05.00207


Rheumatic heart disease is the commonest cardiac disease complicating pregnancy in developing countries. Heart disease accounts for 15% pregnancy related mortality. In the presence of maternal heart disease, the circulatory changes of pregnancy may result in exacerbation of the haemodynamic perturbations due to complex cardiac valvular lesions leading to decomposition or death of mother or foetus. Determining the ideal anesthetic technique for Caesarean section in presence of complex cardiac conditions remains a much debated topic. General anesthesia is associated with a further increase in pulmonary pressure in response to laryngoscope and intubation along with myocardial depression by anesthetic agents. Neuraxial blockade may lead to decrease in SVR and Cardiac output. We report the successful anesthetic management of a parturient suffering from Rheumatic heart disease with multi valvular lesions resulting in severe pulmonary hypertension under epidural anesthesia with good maternal and neonatal outcome. Successful management requires vigilant perioperative monitoring and thorough knowledge of the haemodynamic of complex cardiac valvular disease.

Keywords: Rheumatic heart disease; Multiple valvular lesions; Severe pulmonary hypertension; Caesarean section; Epidural anaesthesia


Prevalence of heart disease in pregnancy varies from 0.3-3.5%. In the presence of maternal heart disease, the circulatory changes of pregnancy may result in decomposition or death of mother or foetus. Severe pulmonary hypertension is poorly tolerated in pregnancy. We shall discuss the anaesthetic management for elective Caesarean section of a young parturient suffering from Rheumatic heart disease with multi valvular involvement and severe pulmonary hypertension in a tertiary care teaching hospital.

Case History

A 20 yr old primigravida with history of rheumatic heart disease with multi valvular lesions and severe pulmonary hypertension was posted for elective Caesarean section at 36 wk of gestation. Preoperative examination revealed history of exceptional breathlessness and chest discomfort since 12 weeks of gestation which gradually occurred on less than ordinary activities with progression of pregnancy. There were no symptoms suggestive of paroxysmal nocturnal dyspnoea, syncope or congestive heart failure. Echocardiography revealed severe mitral regurgitation, moderate mitral stenosis (MVA 1.2sq cm, Pressure gradient 20mmHg), moderate aortic regurgitation and mild tricuspid regurgitation with severe pulmonary hypertension (PASP 75 mm Hg, LVEF 52% with mild LV systolic dysfunction). ECG showed sinus rhythm with bifid P waves (Figure 1). Haematological and biochemical parameters were within normal limit. She was prescribed Tab Metoprolol 25mg twice daily, Tab Frusemide 20mg twice daily, PENTIDS 400mg twice daily, salt restriction, bed rest and was considered to be at a high cardiac risk for pregnancy.

In the operating room, standard ASA monitors were applied. Clinical examination revealed bilateral basal crepitations, tachypnoea, NIBP 113/60 mmHg, MAP 73mmHg, HR 96/min, regular in rhythm, SPO2 100% in room air. Central venous cannulation was done through the Right Internal Jugular Vein for perioperative CVP monitoring. Baseline CVP was 7 cm of H2O.

A graded epidural anaesthesia was planned to maintain haemodynamic stability and to maintain optimum SBP, DBP, HR, CVP and prevent further rise in pulmonary vascular resistance (PVR). Epidural catheter was inserted through L1-L2 inter space with patient seated and was placed 4 cm into the epidural space. Position was confirmed following administration of a test dose of 3 ml of 2% lignocaine with adrenaline. Patient was placed in supine position with a left tilt of 15 degrees to prevent aortocaval compression and a sensory block to T6 dermatome was achieved by 12 ml of 0.5% Bupivacaine in fractionated doses of 3 ml over a period of 20 minutes with 50 microgram Fentanyl. Oxygen was administered by a face mask at 6 litre/min throughout the intra operative period. IV fluid infusion was guided by continuous monitoring of CVP. A male baby of 2.2 kg with Apgar score 9 and 10 at 1 min and 5 min respectively was delivered. Following delivery of the baby 5 units of Oxytocin was administered intramuscularly followed by 5 units in 500 ml of lactated Ringer solution (RL) infused over one hour. Hypotension (BP 116/43mmHg, MAP 70mmHg) occurred after oxytocin infusion which was corrected by intermittent bolus of 50 microgram of Phenylephrine to a total of 300 mcg (Figure 2). Total one litre of RL was infused maintaining a CVP of 5-7 cm of H2O (Figure 3).

Duration of surgery was 60 minutes. Following surgery BP 112/58mmHg, MAP 73mmHg, PR 110/min, SpO2 100% in room air, CVP 5cm H2O was recorded. There was slight improvement of the symptoms with mild decrease in the basal crepitations. Patient was transferred to the critical care unit for observation for 48 hours. Analgesia was maintained with 0.125% Bupivavaine at 5ml/hr infusion and Paracetamol infusion (1 gm in 100ml) 6 hourly. Patient was shifted to the ward after 48 hours. Post operative period was uneventful. Prescribed cardiac drugs were continued throughout the perioperative period. Patient was discharged from the hospital on 7th post operative day after obtaining cardiological consultation for further management of underlying cardiac disease.


Pure or predominant Mitral stenosis occurs in approximately 40% of patients with rheumatic heart disease. The increased blood volume and cardiac output by 30-40% during pregnancy and a further increase in the cardiac output to 80%-100% of pre lab our values following delivery are poorly tolerated by parturient with valvular heart disease like mitral and aortic stenosis. A severe decompensation in myocardial function can develop during third trimester, labor, and immediately after delivery. Cardiac output, heart rate, and stroke volume decrease to pre-labour values by 24 to 72 hours postpartum and return to non-pregnant levels within 6 to 8 weeks after delivery [1].

Severe pulmonary hypertension (PASP>75mmHg), MS with NYHA class II-IV, MR and AR with NYHA class III-IV predispose to a high maternal and fetal morbidity and mortality [2].

Cardiac disease was diagnosed incidentally in this patient at a time when therapeutic termination was not feasible. Caesarean delivery was planned at 36 weeks gestation to maximize fetal lung maturation and to avoid deterioration in maternal cardiac status. Anticoagulants were not prescribed as there was no evidence of thrombi in the LA and ECG showed sinus rhythm.

The choice of anaesthetic technique in this case was a challenge as it involved a rare combination of multiple valvular lesions along with severe pulmonary hypertension. Few cases of complex valvular heart disease in the obstetric patient population have been reported. Besides, the haemodynamic perturbations due to complex lesions were further exacerbated during pregnancy. Anesthetic management was individualized keeping in view the haemodynamic goals relevant to the underlying complex pathophysiology.

Echocardiography findings suggested a normal sized LV with mild global hypokinesia and mild systolic dysfunction (LVEF 52%) and a dilated LA (LAID 4.7 cm) with MVA 1.2 sq cm along with a bifid P wave on ECG. This indicates that MS was the predominant lesion with coexisting MR and AR which had led to an enlarged LA with Pulmonary hypertension. Coexistent MR and AR causes severe volume overload of LV. MS and AR generate opposite loading conditions hence hyperdynamic contractility and LV enlargement may be less evident. Mitral stenosis restricts left ventricular filling and thus diminishing the impact of the aortic regurgitation on left ventricular volume [3].

In this patient, symptoms were predominantly due to longstanding increase in LA volume and pulmonary hypertension along with a mild decrease in LV systolic function. Neuraxial blockade in form of graded epidural anesthesia that allows a gradual onset of block with avoidance of hypotension by intermittent fluid bolus and judicious use of vasopressors has been used successfully in the past [4-8].

Subarachnoid block was avoided to prevent the sudden haemodynamic perturbations. Some authors have described the use of general anesthesia with good maternal outcome [9] whereas; others have reported increased pulmonary arterial pressure during laryngoscopy and tracheal intubation. Adverse effects of positive-pressure ventilation on venous return may lead to cardiac failure. Avoidance of tachycardia is of utmost importance which may be achieved by the use of opioids like Fentanyl before or during the induction of general anesthesia with neonatal respiratory depression as an adverse outcome.

 Weeks & Smith [10] had concluded that although epidural anesthesia has been used with success, but in preexisting RHF large decrease in SVR may cause further decrease in CO. On the other hand GA may cause increase PVR in response to laryngoscopy, intubation and negative isotropic effects of anaesthetic agents. According to Gomar C and coworker [11], with the exception of Tetralogy of Fallot, primary pulmonary hypertension, idiopathic hypertrophic subaortic stenosis, and anticoagulation, neuraxial techniques with low segmental blockade of dermatomes offer an alternative to general anesthesia in parturient with cardiac disease during Caesarean section. Adequate cardiovascular invasive monitoring is essential and should be administered and maintained in the postpartum period with the same criteria that reduce morbidity and mortality in cardiac patients undergoing general surgery.

Keeping the underlying pathophysiology in view, we aimed to maintain haemodynamic stability by maintaining an optimum SVR, preload, heart rate, sinus rhythm and avoiding myocardial depression and increase in pulmonary vascular resistance. This was achieved by epidural anesthesia in a graded manner using small fractionated doses of local anaesthetic to ensure a gradual onset of block and minimize haemodynamic changes resulting from sympathetic autonomic blockade. We chose to avoid general anesthesia in our patient in order to prevent the rise in pulmonary vascular resistance and worsening of pulmonary hypertension resulting from sympathetic stimulation during laryngoscopy, intubation and nitrous oxide inhalation and to prevent myocardial depression in response to anaesthetics. We administered oxytocin by intramuscular route and by slow intravenous infusion to avoid tachycardia and diastolic hypotension [12]. Agents that increase in PVR like methylergometrine, prostaglandin F2 alpha, hypothermia, hypoxia and inadequate analgesia were strictly avoided [13].

 SVR and CO increase after delivery which is a critical period for patients with Pulmonary HT and thereby require vigilant postoperative monitoring. Keeping this is view we had monitored the patient closely for 48 hours in the intensive care unit. Epidural anesthesia provides a safer alternative to general anaesthesia in parturient with complex valvulvar lesions. However, it is easier said than done. Successful management necessitates strict vigilance and an extremely cautious approach to maintain the haemodynamic stability throughout the peripartum period.


  1. Datta S, Kodali BS, Segal S (2010) Obstetric Anaesthesia handbook. (5th edn.), Springer, Boston, USA.
  2. Harnett M, Tsen LC (2009) Cardiovascular disease. In: Chestnut DH, Polley LS, Tsen LC (Eds.) Chestnut’s Obstetric Anaesthesia: Pinciples and Practice. (4th edn.), Mosby Elsevier, Philadelphia (PA), USA, pp. 883-884.
  3. Langesaeter E, Dragsund M, Rosseland LA (2010) Regional anaesthesia for a Caesarean section in women with cardiac disease: A prospective study. Acta Anaesthesiol Scand 54(1): 46-54.  
  4. Sharma SK, Gabling DR, Gajraj NM, Truong C, Sidawi EJ (1994) Anaesthetic management of a parturient with mixed mitral valve disease and uncontrolled atrial fibrillation. Int J Obstet Anaesth 3(3): 157-162.
  5. Gash AK, Carabello BA, Kent RL, Frazier JA, Spann JF (1984) Left ventricular performance in patients with coexistent mitral stenosis and aortic insufficiency. J Am Coll Cardiol 3(3): 703-711.
  6. Celik M, Dostbil A, Alici HA, Sevimli S, Aksoy A, et al. (2013) Anaesthetic Management for Caesarean Section Surgery in Two Pregnant Women with Severe Pulmonary Hypertension Due to Mitral Valve Stenosis. Balkan Med J 30: 439-441.
  7. Harsoor SS, Joshi SD (2005) Anaesthetic management of parturient with primary pulmonary hypertension posted for caesarean section-A Case Report. Indian J Anaesth 49(3): 223-225.
  8. Kannan M, Vijayanand G (2010) Mitral stenosis and pregnancy: Current concepts in anaesthetic practice. Indian J Anaesth 54(5): 439-444.
  9. Coskun D, Mahli A, Corkmaz S, Demir FS, Inan GK, et al. (2009) Anaesthesia for caesarean section in the presence of multivalvular heart disease and severe pulmonary hypertension: a case report. Cases J 2: 9383.
  10. Weeks SK, Smith JB (1991) Obstetric Anaesthesia in patients with primary pulmonary hypertension. Can J Anaesth 38(7): 814-816.
  11. Gomar C, Errando CL (2005) Neuroaxial anaesthesia in obstetrical patients with cardiac disease. Curr Opin Anaesthesiol 18(5): 507-512.
  12. Dyer RA, Butwick AJ, Carvalho B (2011) Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Curr Opin Anesthesiol 24(3): 255-261.
  13. Secher NJ, Arnsbo P, Wallin L (1978) Haemodynamic effects of oxytocin (syntocinon) and methyl ergometrine (methergin) on the systemic and pulmonary circulations of pregnant anaesthetized women. Acta Obstet Gynecol Scand 57(2): 97-103.
© 2014-2018 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy